RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,379,993 | -22.8% | 583,642 | -25.9% | 0.28% | +6.0% |
| Q2 2019 | $17,321,000 | -19.7% | 787,300 | 0.0% | 0.27% | -19.8% |
| Q1 2019 | $21,580,000 | -13.5% | 787,300 | -15.2% | 0.33% | -27.7% |
| Q4 2018 | $24,958,000 | -17.8% | 928,500 | -10.8% | 0.46% | +26.2% |
| Q3 2018 | $30,376,000 | -52.9% | 1,041,353 | -49.6% | 0.37% | -52.5% |
| Q2 2018 | $64,552,000 | +11.8% | 2,065,000 | -28.8% | 0.77% | +7.5% |
| Q1 2018 | $57,736,000 | +32.7% | 2,901,295 | 0.0% | 0.72% | +30.2% |
| Q4 2017 | $43,519,000 | – | 2,901,295 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |